Literature DB >> 11737592

Cellular overexpression of heme oxygenase-1 up-regulates p21 and confers resistance to apoptosis.

P Inguaggiato1, L Gonzalez-Michaca, A J Croatt, J J Haggard, J Alam, K A Nath.   

Abstract

BACKGROUND: Induction of heme oxygenase-1 (HO-1) protects against diverse insults in the kidney and other tissues. We examined the effect of overexpression of HO-1 on cell growth, expression of p21, and susceptibility to apoptosis.
METHODS: LLC-PK1 cells were genetically engineered to exhibit stable overexpression of HO-1. The effects of such overexpression on cell growth, the cell cycle, and the cell cycle-inhibitory protein, p21, were assessed; additionally, the susceptibility of these HO-1 overexpressing cells to apoptosis induced by three different stimuli (TNF-alpha/cycloheximide, staurosporine, or serum deprivation) was evaluated by such methods as the quantitation of caspase-3 activity, phase contrast microscopy, and the TUNEL method.
RESULTS: HO-1 overexpressing LLC-PK1 cells demonstrated cellular hypertrophy, decreased hyperplastic growth, and growth arrest in the G0/G1 phase of the cell cycle. HO-1 overexpressing cells were markedly resistant to apoptosis induced by TNFalpha/cycloheximide or staurosporine as assessed by the caspase-3 activity assay. Such overexpression also conferred resistance to apoptosis induced by serum deprivation as evaluated by the TUNEL method; in these studies, inhibition of HO attenuated the resistance to apoptosis. Expression of the cyclin dependent kinase inhibitor, p21CIP1, WAF1, SDI1, as judged by Northern and Western analyses, was significantly increased in HO-1 overexpressing cells, and decreased as HO activity was inhibited. Moreover, this reduction in expression of p21 attendant upon the inhibition of HO activity in HO-1 overexpressing cells paralleled the loss of resistance of these cells to apoptosis when HO activity is inhibited. The pharmacologic inducer of HO-1, hemin, increased expression of p21 in wild-type cells and decreased apoptosis provoked by TNF-alpha/cycloheximide.
CONCLUSION: Cellular overexpression of HO-1 up-regulates p21, diminishes proliferative cell growth, and confers marked resistance to apoptosis. We speculate that such up-regulation of p21 contributes to the altered pattern of cell growth and resistance to apoptosis. Our studies uncover the capacity of HO-1 to markedly influence the cell cycle in renal epithelial cells. In light of the profound importance of the cell cycle as a determinant of cell fate, we speculate that the inductive effect of HO-1 on p21 and the attendant inhibitory effect on the cell cycle provide a hitherto unsuspected mechanism underlying the cytoprotective actions of HO-1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11737592     DOI: 10.1046/j.1523-1755.2001.00046.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  33 in total

1.  Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury.

Authors:  Kiyoshi Mori; H Thomas Lee; Dana Rapoport; Ian R Drexler; Kirk Foster; Jun Yang; Kai M Schmidt-Ott; Xia Chen; Jau Yi Li; Stacey Weiss; Jaya Mishra; Faisal H Cheema; Glenn Markowitz; Takayoshi Suganami; Kazutomo Sawai; Masashi Mukoyama; Cheryl Kunis; Vivette D'Agati; Prasad Devarajan; Jonathan Barasch
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

2.  Anomalous renal effects of tin protoporphyrin in a murine model of sickle cell disease.

Authors:  Julio P Juncos; Joseph P Grande; Narayana Murali; Anthony J Croatt; Luis A Juncos; Robert P Hebbel; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

3.  Cytoprotection behind heme oxygenase-1 in renal diseases.

Authors:  Matheus Correa-Costa; Mariane Tami Amano; Niels Olsen Saraiva Câmara
Journal:  World J Nephrol       Date:  2012-02-06

4.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2002

5.  Renoprotective effect of platelet-rich plasma in obstructive uropathy.

Authors:  Emrah Özsoy; Musab Ali Kutluhan; Mehmet Akyüz; Emre Tokuç; Ahmet Ürkmez; Gülistan Gümrükçü; Metin İshak Öztürk
Journal:  Int Urol Nephrol       Date:  2021-01-29       Impact factor: 2.370

6.  Plasma and urinary heme oxygenase-1 in AKI.

Authors:  Richard A Zager; Ali C M Johnson; Kirsten Becker
Journal:  J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 10.121

7.  Plasma and urinary p21: potential biomarkers of AKI and renal aging.

Authors:  Ali C Johnson; Richard A Zager
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-01

8.  Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse.

Authors:  Matthias H Kapturczak; Clive Wasserfall; Todd Brusko; Martha Campbell-Thompson; Tamir M Ellis; Mark A Atkinson; Anupam Agarwal
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

9.  Fatty acid transduction of nitric oxide signaling: nitrolinoleic acid potently activates endothelial heme oxygenase 1 expression.

Authors:  Marcienne M Wright; Francisco J Schopfer; Paul R S Baker; Vijay Vidyasagar; Pam Powell; Phil Chumley; Karen E Iles; Bruce A Freeman; Anupam Agarwal
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

10.  The heme oxygenase-1 genotype is a risk factor to renal impairment of IgA nephropathy at diagnosis, which is a strong predictor of mortality.

Authors:  Ho Jun Chin; Hyun Jin Cho; Tae Woo Lee; Ki Young Na; Hyung Jin Yoon; Dong-Wan Chae; Suhnggwon Kim; Un Sil Jeon; Jun-Young Do; Jong-Won Park; Kyung-Woo Yoon; Young-Tai Shin; Kang Wook Lee; Ki-Ryang Na; Dae Ryong Cha; Young Sun Kang
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.